Colorado Chromatography Labs was founded in the summer of 2020 in the ashes of the original Colorado Chromatography. Colorado Chromatography was originally a THC remediation business founded by Alex and Kyle in May of 2019. During this time, the original Colorado Chromatography gained a reputation of excellence in post-processing and was known for its scientific approach to cannabis. Despite their best efforts, the underfunded Colorado Chromatography was destined for demise in the early spring of 2020, right as the global COVID-19 Pandemic was taking hold. That is when Kyle and Alex met the current CEO of Colorado Chromatography Labs, Tim Smith.
Tim had recently made a successful exit from his company in the Energy sector and was looking to invest in hemp. Tim, Alex, and Kyle originally decided to join forces and create Colorado Chromatography Labs in order to pursue THC-free Distillate and custom formulations. However, the group strategically decided that they would need to do more to differentiate themselves in the hemp space. The group decided to invest heavily into Research and Development and go after minor cannabinoids in order to control their supply chain and ensure quality. However, the trio knew that they would need additional scientific expertise in order to successfully achieve their goals, that is where the current CSO Westley Cruces comes into the picture.
With the knowledge and industry influence of the newest team member Westley, Colorado Chromatography Labs began to come into its own. Within two months from inception, the full CCL team had made CBN Isolate at >95% purity and began sales. Despite ongoing difficulties with finding suitable laboratory space for R&D as well as production, Colorado Chromatography Labs preserved and now has Laboratories/Offices in Colorado, Texas, and New Mexico. CCL has a fixation on excellence and has always strived to produce only the highest quality minor cannabinoids in the cannabis industry.
Today, Colorado Chromatography Labs is an industry leader in the Production of 99%+ CBN and has a number of other minor cannabinoids currently in the process of being scaled and rolled out for production including HHC, CBC, THCV, and CBDV. As always, CCL is fixated on excellence and continues to push the boundaries to create innovative solutions to an ever-evolving marketplace.